SIS Medical AG has moved to its new production facility in Frauenfeld, Switzerland. From this new location, the company is capable of providing higher capacity to meet the increasing demand for balloon catheters in international markets. Following the move, significant investments will be made to strengthen its R&D department as well.
During the coming quarters, the company will significantly increase its investments in the development of new products as well as international market registrations. Production in Frauenfeld has obtained ISO 13485 and ISO 9001 certification and is providing the highest safety and quality standards.
SIS Medical currently employs 30 people and will significantly increase its number of employees in the months to come by hiring additional professionals, a number of which will include highly qualified R&D engineers.
SIS Medical’s high-pressure balloons are in international demand by interventional cardiologists, as the products offer additional treatment options including the reopening of highly calcified arteries or the optimization of stent results, for example, in combination with the implantation of bioabsorbable stents for predilation and postdilation.
“With the new facility, we have established additional capacity with certified high quality and safety standards. This will serve as the foundation for significant additional international growth,” said CEO and founder, Willi Zwahlen.
SIS Medical AG
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]